BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29360338)

  • 1. Liposome-Protamine-DNA Nanoparticle-Mediated Delivery of Short Hairpin RNA Targeting Brachyury Inhibits Chordoma Cell Growth.
    Hu Y; Singh R; Deng Z; Mintz A; Hsu W
    J Biomed Nanotechnol; 2016 Oct; 12(10):1952-61. PubMed ID: 29360338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
    Hu Y; Mintz A; Shah SR; Quinones-Hinojosa A; Hsu W
    Carcinogenesis; 2014 Jul; 35(7):1491-9. PubMed ID: 24445144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
    Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
    J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.
    Nelson AC; Pillay N; Henderson S; Presneau N; Tirabosco R; Halai D; Berisha F; Flicek P; Stemple DL; Stern CD; Wardle FC; Flanagan AM
    J Pathol; 2012 Nov; 228(3):274-85. PubMed ID: 22847733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.
    Sheppard HE; Dall'Agnese A; Park WD; Shamim MH; Dubrulle J; Johnson HL; Stossi F; Cogswell P; Sommer J; Levy J; Sharifnia T; Wawer MJ; Nabet B; Gray NS; Clemons PA; Schreiber SL; Workman P; Young RA; Lin CY
    Cell Rep Med; 2021 Jan; 2(1):100188. PubMed ID: 33521702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
    Yamaguchi T; Imada H; Iida S; Szuhai K
    Surg Pathol Clin; 2017 Sep; 10(3):637-656. PubMed ID: 28797506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
    Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
    BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From notochord formation to hereditary chordoma: the many roles of Brachyury.
    Nibu Y; José-Edwards DS; Di Gregorio A
    Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death.
    Cottone L; Cribbs AP; Khandelwal G; Wells G; Ligammari L; Philpott M; Tumber A; Lombard P; Hookway ES; Szommer T; Johansson C; Brennan PE; Pillay N; Jenner RG; Oppermann U; Flanagan AM
    Cancer Res; 2020 Oct; 80(20):4540-4551. PubMed ID: 32855205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule targeting of brachyury transcription factor addiction in chordoma.
    Sharifnia T; Wawer MJ; Chen T; Huang QY; Weir BA; Sizemore A; Lawlor MA; Goodale A; Cowley GS; Vazquez F; Ott CJ; Francis JM; Sassi S; Cogswell P; Sheppard HE; Zhang T; Gray NS; Clarke PA; Blagg J; Workman P; Sommer J; Hornicek F; Root DE; Hahn WC; Bradner JE; Wong KK; Clemons PA; Lin CY; Kotz JD; Schreiber SL
    Nat Med; 2019 Feb; 25(2):292-300. PubMed ID: 30664779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle.
    Kobayashi Y; Sugiura T; Imajyo I; Shimoda M; Ishii K; Akimoto N; Yoshihama N; Mori Y
    Int J Oncol; 2014 Apr; 44(4):1107-17. PubMed ID: 24504414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T-box transcription factor Brachyury promotes renal interstitial fibrosis by repressing E-cadherin expression.
    Sun S; Sun W; Xia L; Liu L; Du R; He L; Li R; Wang H; Huang C
    Cell Commun Signal; 2014 Nov; 12():76. PubMed ID: 25433496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.
    Xu K; Liu B; Liu Y
    Mol Med Rep; 2015 Jul; 12(1):995-1001. PubMed ID: 25683840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
    Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
    Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.
    Shalaby AA; Presneau N; Idowu BD; Thompson L; Briggs TR; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2009 Aug; 22(8):996-1005. PubMed ID: 19407855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
    Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
    J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#).
    Szuhai K; Hogendoorn PC
    J Pathol; 2012 Nov; 228(3):261-5. PubMed ID: 22952146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.